About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Role of Positive Affect in Adjustment to HIV | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00582023

Role of Positive Affect in Adjustment to HIV

The purpose of this study is to examine the role of emotion and mood in the context of HIV.

Lead sponsor: University of California, San Francisco•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of California, San Francisco

Collaborators

National Institute of Mental Health (NIMH)

A growing body of literature indicates that positive affect may have a unique adaptive role in the process of adjustment to chronic stress, independent of the effects of negative affects like depression. The overarching goal of this research is to provide evidence and direction for the development of interventions for people with HIV that include a focus on positive affect. To this end, this study will document the occurrence, predictors, and consequences of positive affect during the 18 months post-notification of HIV+ serostatus.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Have been informed they were HIV positive within the past two months
•Speak English
•Be 18 years or older
•Have the ability to provide informed consent to be a research participant

Exclusion Criteria

•Severe cognitive impairment
•Active psychosis

Related studies

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047 · HIV, HIV Infections

WiseApp for Spanish Speakers Living With HIV

NCT05398185 · HIV Infections, Acquired Immune Deficiency Syndrome, and more

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330 · Cervix Cancer, HIV Infections, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 25, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment160

Start dateSep 2004

Last updatedNov 25, 2013

Condition

Locations shown

Osher Center for Integrative Medicine, UCSF

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 25, 2013Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions